Results 101 to 110 of about 1,162,217 (215)
Long-term survival outcomes of neoadjuvant chemotherapy in stage II-III HR+/HER2- breast cancer
Breast cancer is the most common malignant tumor among women worldwide. Hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer is the largest subgroup among these cases.
Jiaxing Liu +11 more
doaj +1 more source
Excess urinary iodine concentration and thyroid dysfunction among school age children of eastern Nepal: a matter of concern [PDF]
Man Kumar Tamang +5 more
openalex +1 more source
Objective. To compare insulin surrogate indices with the homeostasis model assessment of insulin resistance (HOMA-IR) in Thai people with type 2 diabetes (T2D). Methodology.
Waralee Chatchomchuan +5 more
doaj +1 more source
Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer [PDF]
Christophe Bouvet +9 more
openalex +1 more source
Functional radical cervical dissection for differentiated thyroid cancer: the experience of a single center [PDF]
There is ongoing debate regarding the role of neck dissection in differentiated thyroid cancer, about its usefulness in elective settings, and the increased costs regarding morbidity and operative time.
Adrian, Tulin +12 more
core +1 more source
Triple-negative breast cancer (TNBC) is an aggressive subtype with a relatively poor prognosis, and its natural history without therapeutic intervention remains understudied.
Dasong Wang +7 more
doaj +1 more source
Early postoperative levothyroxine initiation after total thyroidectomy for Graves’ disease
No evidence-based standards exist regarding levothyroxine (LT4) replacement therapy initiation timing in patients with hyperthyroid Graves’ disease undergoing total thyroidectomy.
Yuji Nagayama +11 more
doaj +1 more source
Mengdi Zhang,1 Dongqing Pu,2 Feifei Meng,1 Guangxi Shi,2 Jingwei Li2 1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan City, People’s Republic of China; 2Department of Thyroid and Breast Diagnosis and Treatment ...
Zhang M, Pu D, Meng F, Shi G, Li J
doaj
Background Papillary thyroid cancer (PTC) is a malignant tumor that poses a serious threat to human health. LncRNA CASC9 serves as an oncogene in numerous tumors.
Jianping Yu +4 more
doaj +1 more source

